Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Taouli, Bachir

Icahn School Of Medicine At Mount Sinai
United States

Abbreviated MRI for HCC screening in cirrhotic patients 5R01CA249765-04 Guillermo Marquez, Ph.D.
Tayob, Nabihah

Dana-Farber Cancer Inst
United States

Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma 5R01CA230503-06
Temprosa, Marinella

George Washington University
United States

22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center 2U01DK048489-28 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Temprosa, Marinella

George Washington University
United States

22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center 2U01DK048489-28 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Temprosa, Marinella

George Washington University
United States

22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center 2U01DK048489-28 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Temprosa, Marinella

George Washington University
United States

22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center 2U01DK048489-28 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Terry, Kathryn L

Brigham And Women'S Hospital
United States

Changing Contraceptive Patterns and Ovarian Cancer Risk 5R01CA258679-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Goli Samimi, Ph.D., M.P.H.
Thakur, Mathew Laxman

Thomas Jefferson University
United States

Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer 5R01CA249921-04 Richard Mazurchuk, Ph.D.
Thangaraju, Muthusamy

Augusta University
United States

Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis 1R01CA275840-01A1 Winfred Malone, Ph.D., M.P.H.
Thomas, Christoforos

Methodist Hospital Research Institute
United States

Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome 5R21CA267386-03 PAR-20-292 (R21 Clinical Trial Optional) Winfred Malone, Ph.D., M.P.H.